drugset / Trial / NCT05957848
Guanfacine Extended-release for Adolescents With Cannabis Use
Phase 2
Recruiting
100 enrolled
Orygen
University of Melbourne · collabYouth Support and Advocacy Service · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A randomized controlled trial to assess the efficacy of extended-release guanfacine to reduce cannabis use frequency in young people with cannabis use disorder following a period of monitored abstinence.
Timeline
- Start
- 2023-07-27
- Primary completion
- 2025-12-31
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guanfacine | Small molecule | 4 mg | Oral |